Animals

Pharma

Loyal's LOY-002 Clears Two of Three FDA Gates as the First Longevity Drug Approval in Any Species Nears

Apr 12, 2026

•

5 min read

Loyal's LOY-002 Clears Two of Three FDA Gates as the First Longevity Drug Approval in Any Species Nears

Loyal's LOY-002, a daily pill designed to extend healthy lifespan in senior dogs, has cleared two of three FDA technical gates after completing the largest clinical trial in veterinary medicine.

Aaron Rafferty

Healthcare

Two People Used AI to Treat Cancer When Institutions Couldn't. Both Worked.

Mar 28, 2026

•

4 min read

Two People Used AI to Treat Cancer When Institutions Couldn't. Both Worked.

A tech CEO used AI to direct his own cancer treatment into remission. A developer used AI to design an mRNA vaccine for his dog's cancer. Both bypassed institutional gatekeeping.

Aaron Rafferty

Animals

Loyal's LOY-002 Clears Two of Three FDA Gates as the First Longevity Drug Approval in Any Species Nears

Two People Used AI to Treat Cancer When Institutions Couldn't. Both Worked.

WYDE Newsroom